Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 5.20T | 7.55T | 4.61T | 1.46T | 410.90B |
Gross Profit | 3.42T | 4.16T | 2.65T | 904.85B | 287.38B |
EBITDA | 520.69B | 743.02B | 445.57B | 118.65B | 65.18B |
Net Income | 360.41B | 341.58B | 399.02B | 57.01B | 29.55B |
Balance Sheet | |||||
Total Assets | 14.72T | 6.11T | 1.96T | 1.03T | 688.97B |
Cash, Cash Equivalents and Short-Term Investments | 2.07T | 1.99T | 913.64B | 385.42B | 279.68B |
Total Debt | 1.11T | 64.41B | 24.10B | 15.14B | 1.17B |
Total Liabilities | 12.10T | 4.70T | 1.59T | 867.58B | 584.21B |
Stockholders Equity | 2.58T | 1.40T | 360.48B | 159.41B | 102.62B |
Cash Flow | |||||
Free Cash Flow | -5.34T | 559.08B | 94.07B | 108.67B | -13.29B |
Operating Cash Flow | -5.17T | 601.23B | 110.48B | 116.71B | -10.14B |
Investing Cash Flow | -162.40B | -43.00B | -27.15B | -7.50B | -2.70B |
Financing Cash Flow | 7.89T | -26.46B | -5.92B | -5.37B | -10.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $7.75B | 10.98 | 12.73% | 2.40% | 6.27% | 45.08% | |
79 Outperform | $1.19B | 9.41 | 17.20% | 3.31% | -2.96% | -7.14% | |
74 Outperform | $3.21B | 8.34 | 15.46% | 3.37% | -48.81% | 0.18% | |
74 Outperform | $4.34B | 988.47 | 0.11% | 3.21% | -46.30% | -79.35% | |
70 Outperform | $2.69B | 10.50 | 8.98% | 3.36% | -2.81% | 51.85% | |
70 Outperform | $8.43B | 10.04 | 12.58% | 1.98% | 7.06% | 14.94% | |
65 Neutral | £5.15B | 8.78 | 6.90% | 5.08% | 20.28% | -10.03% |